Ftse Mib
34.171,69
0,03%
DAX
19.909,14
-0,25%
S&P 500
5.932,99
-0,63%
NASDAQ
19.581,54
-0,71%
Bitcoin
94.216,97
0,75%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Gsk Plc (GSK) Gsk Plc (GSK) Notizie

Gsk Plc

GSK
1.334,00
-8,50 (-0,63%)
30 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
23/12/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
20/12/202410:00LSEG_RNSGSK PLC Block Listing Application
20/12/202409:58ALNCNewsGSK reports mixed findings from ovarian cancer phase III..
20/12/202408:00LSEG_RNSGSK PLC Headline results from phase III FIRST trial
16/12/202410:34ALNCNewsGSK receives three positive regulatory updates on cancer..
16/12/202408:11LSEG_RNSGSK PLC Jemperli receives US FDA breakthrough designation
16/12/202408:05LSEG_RNSGSK PLC EMA grants PRIME Designation for GSK’227
16/12/202408:00LSEG_RNSGSK PLC Jemperli receives positive CHMP opinion
12/12/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
09/12/202420:42ALNCNewsIN BRIEF: GSK highlights positive Blenrep data from Dreamm-7..
09/12/202419:29LSEG_RNSGSK PLC Overall survival data presented for Blenrep
09/12/202409:47ALNCNewsGSK's Nucala and Blenrep receive regulatory boost in US and..
09/12/202408:05LSEG_RNSGSK PLC Blenrep combination China filing acceptance
09/12/202408:00LSEG_RNSGSK PLC Nucala COPD submission accepted by US FDA
05/12/202410:19ALNCNewsGSK expands Chinese shingles vaccine collaboration with..
05/12/202408:00LSEG_RNSGSK PLC Zhifei China collaboration revised and extended
02/12/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
02/12/202416:00LSEG_RNSGSK PLC Total Voting Rights
27/11/202410:23ALNCNewsTOP NEWS: GSK hails EU Approval of Menveo vaccine in new..
27/11/202408:00LSEG_RNSGSK PLC GSK liquid meningitis vaccine authorised in EU
25/11/202409:54ALNCNewsGSK's Blenrep combinations accepted for review by US FDA
25/11/202408:00LSEG_RNSGSK PLC Blenrep combinations accepted for US FDA review
22/11/202409:40ALNCNewsTOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for..
22/11/202408:00LSEG_RNSGSK PLC Japan approves first RSV vaccine for adults 50-59
19/11/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
19/11/202410:24ALNCNewsGSK hails positive results for linerixibat in treating..
19/11/202408:00LSEG_RNSGSK PLC GLISTEN Trial of Linerixibat Meets Endpoint
14/11/202409:54ALNCNewsGSK hails survival results in blood cancer patients with..
14/11/202408:00LSEG_RNSGSK PLC GSK announces overall survival results for Blenrep
13/11/202416:00LSEG_RNSGSK PLC Block listing Interim Review
12/11/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
11/11/202416:01LSEG_RNSGSK PLC GSK publishes provisional 2025 dividend dates
04/11/202417:16ALNCNewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as..
01/11/202416:00LSEG_RNSGSK PLC Total Voting Rights
30/10/202415:29LSEG_RNSGSK PLC Director/PDMR Shareholding
30/10/202410:28ALNCNewsTOP NEWS: GSK backs guidance despite third-quarter hit from..
30/10/202408:00LSEG_RNSGSK PLC 3rd Quarter Results
29/10/202413:48ALNCNewsGSK inks deal to buy lupus therapy from Chimagen for USD300..
24/10/202410:22ALNCNewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential..
24/10/202408:00LSEG_RNSGSK PLC New positive Arexvy data in younger adults at risk
17/10/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
16/10/202417:09LSEG_RNSGSK PLC Director/PDMR Shareholding
16/10/202409:33ALNCNewsGSK's application for urinary tract infections drug is..
16/10/202408:00LSEG_RNSGSK PLC FDA accepts new drug application for gepotidacin
14/10/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
14/10/202409:54ALNCNewsTOP NEWS: GSK gets positive result from sinus disease..
14/10/202408:00LSEG_RNSGSK PLC Positive results of ANCHOR trials of depemokimab
11/10/202416:33LSEG_RNSGSK PLC Director/PDMR Shareholding
10/10/202416:30LSEG_RNSGSK PLC Director/PDMR Shareholding
10/10/202412:48IHMARKETNEWSU.S. Futures Fall Slightly as Investors Await CPI Data; Oil..
Apertura: 1.341,50 Min: 1.330,50 Max: 1.346,00
Chiusura: 1.342,50

La tua Cronologia

LSE
GSK
Gsk
BIT
NSCIT0054535
Valsabbina SME 3 SPV
BIT
EGB5
ETFS 5x Long GBP Short EUR
BIT
ACWI
ETF
BIT
XMRC
Xtrackers Msci Russia Ca...
BIT
F33998
Vontobel Financial Produ...
BIT
REN
Renergetica
BIT
S28931
Societe Generale Effekten
BIT
I07851
Intesa Sanpaolo
BIT
BP1033
IT0005610339 20290927 7....
BIT
I08678
Intesa Sanpaolo
BIT
S29326
Societe Generale Effekten
BIT
UC7A8L
Unicredit Bank
BIT
UC1C56
Unicredit Bank
BIT
S29628
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network